DXR

Daxor Corporation NASDAQ Listed Jul 25, 1983

Healthcare ·Medical - Instruments & Supplies ·US · daxor.com

$9.74

Mkt Cap $49.1M

52w Low $7.13 34.2% of range 52w High $14.76

50d MA $10.51 200d MA $11.88

P/E (TTM) 5.7x

EV/EBITDA 8.0x

P/B 1.1x

Debt/Equity 0.0x

ROE -19.8%

P/FCF -121.7x

RSI (14) —

ATR (14) —

Beta 0.14

50d MA $10.51

200d MA $11.88

Avg Volume 9.9K

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

CIK (SEC)

27367

Phone

12123308500

109 Meco Lane · Oak Ridge, TN 37830 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Jun 29, 2024	AMC	—	-0.34	—	—	—	—	—	—	—	—	—
May 16, 2024	AMC	—	0.72	—	9.50	+0.0%	+0.5%	+1.5%	-0.1%	-1.9%	+1.8%	—
Aug 28, 2023	AMC	—	-0.32	—	9.59	+2.2%	+3.2%	-1.7%	-0.8%	+0.4%	+2.9%	—
Mar 1, 2023	AMC	—	0.81	—	8.25	-3.0%	+5.5%	+1.5%	+5.7%	-6.2%	+6.2%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 17	Ascendiant Capital	Maintains	Buy → Buy	—	$8.18	$8.49	+3.8%	-2.6%	+1.0%	+2.7%	+1.5%	-0.7%
Sep 9	Ascendiant Capital	Maintains	Buy → Buy	—	$8.70	$9.48	+9.0%	+3.4%	+5.3%	-3.6%	+2.5%	-3.5%
Jul 29	Maxim Group	Maintains	Buy → Buy	—	$8.24	$9.39	+14.0%	+19.5%	-1.9%	-5.4%	+3.3%	+0.6%
May 16	Ascendiant	Maintains	Buy → Buy	—	$9.52	$9.81	+3.0%	-0.7%	+2.2%	-7.8%	-9.0%	-0.2%
May 16	Ascendiant Capital	Maintains	Buy → Buy	—	$9.52	$9.81	+3.0%	-0.7%	+2.2%	-7.8%	-9.0%	-0.2%

Data updated apr 25, 2026 6:09am · Source: massive.com